search
Back to results

Parental Touch Trial (Petal) (Petal)

Primary Purpose

Infant Development, Pain, Procedural, Parents

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Parental touch
Sponsored by
Paediatric Neuroimaging Research Group
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Infant Development focused on measuring Parental touch, Brain activity, Stroking, Anxiety, Clinical pain score, Heart rate, Respiratory rate

Eligibility Criteria

0 Days - 7 Days (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Participants born at the John Radcliffe Hospital, Oxford or the Royal Devon and Exeter Hospital, Devon
  • Neonates born at or after 35+0 weeks gestation
  • Neonates with a postnatal age of 7 days or less
  • Neonates who clinically require a heel lance
  • Neonates for whom parents/guardians have given written informed consent for inclusion in the trial

Exclusion Criteria:

  • Intraventricular haemorrhage (IVH) > grade II
  • Received any analgesics or sedatives in the last 24 hours
  • Congenital malformation or genetic condition known to affect neurological development
  • Born to mothers who have a history of substance abuse.

Sites / Locations

  • Oxford University Hospitals NHS Foundation Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Parental touch (pre-procedural)

Parental touch (post-procedural)

Arm Description

Parents will stroke their baby on the posterior lower limb of the leg where the heel lance will be administered, at a speed of 3cm/s for 10 seconds using the whole hand and in one direction down the limb towards the foot. This will happen just before the control procedure and clinical heel lance.

Parents will stroke their baby on the posterior lower limb of the leg where the heel lance was administered, at a speed of 3cm/s for 10 seconds using the whole hand and in one direction down the limb towards the foot. This will happen just after the control procedure and clinical heel lance.

Outcomes

Primary Outcome Measures

Magnitude of noxious-evoked brain activity
An electroencephalography (EEG) template based on the Principal Component that reflects the noxious-evoked brain activity in neonates has been defined and validated in independent data sets (Hartley 2017). This template will be projected onto the EEG data recorded in the 1000ms period following each heel lance and heel lance control stimulus and the relative weight of the component calculated for each neonate. A greater weight indicates a stronger noxious-evoked response.

Secondary Outcome Measures

Premature Infant Pain Profile - Revised score (PIPP-R score)
PIPP-R is a composite measure encompassing behavioural, physiological and contextual indicators involved in the pain response. These include gestational age, behavioural state, heart rate, oxygen saturation, and duration of brow bulge, eye squeeze, and nasolabial furrow. Each indicator in the PIPP-R is rated on a 4-point scale (0, 1, 2, and 3); these are summed together to produce a maximum possible score of 21, and minimum possible score of 0. In the revised PIPP-R, the scores for the contextual indicators (gestational age and behavioural state) are only included if a non-zero score is recorded for either the physiological or behavioural variables (Stevens et al., 2014). A higher score suggests a greater pain response.
Percentage of neonates who develop tachycardia
Percentage of neonates who develop post-procedural tachycardia (in the 30 seconds post-heel lance). Tachycardia will be defined as a heart rate >160 beats per minute as per Advanced Paediatric Life Support guidelines, reflecting heart rate values >90th centile for newborns in the first week of life (Fleming et al., 2011; Schwartz et al., 2002).
Parental anxiety
Anxiety score from the 20-point Stait Trait Anxiety Inventory (STAI), the gold standard for state anxiety. It is well validated and publicly available. The STAI has a trait (STAI-T) and a state version (STAI-S). The STAI-T scale consists of 20 statements that ask people to describe how they generally feel. The STAI-S scale also consists of 20 statements, but the instructions require subjects to indicate how they feel at a particular moment in time. The STAI-S scale can be used to determine the actual levels of anxiety intensity induced by stressful procedures. Each question is rated on a 4-point scale (not at all, somewhat, moderately so, very much so). The range of possible scores for form Y of the STAI varies from a minimum score of 20 to a maximum score of 80 on both the STAI-T and STAI-S subscales. STAI scores are commonly classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).

Full Information

First Posted
May 13, 2021
Last Updated
February 27, 2023
Sponsor
Paediatric Neuroimaging Research Group
Collaborators
Wellcome Trust, University of Oxford, BLISS charity
search

1. Study Identification

Unique Protocol Identification Number
NCT04901611
Brief Title
Parental Touch Trial (Petal)
Acronym
Petal
Official Title
A Randomised Controlled Trial to Investigate the Effects of Parental Touch on Relieving Acute Procedural Pain in Neonates
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
February 7, 2023 (Actual)
Study Completion Date
February 7, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Paediatric Neuroimaging Research Group
Collaborators
Wellcome Trust, University of Oxford, BLISS charity

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a two centre two-arm randomised controlled interventional trial. We aim to determine whether parental touch prior to a painful clinical procedure provides effective analgesia in neonates.
Detailed Description
This is a multicentre randomised-controlled interventional trial, with two research sites (John Radcliffe Hospital, Oxford, and Royal Devon and Royal Devon and Exeter Hospital, Devon). In this study we aim to determine whether parental touch prior to a painful clinical procedure provides effective analgesia. The primary objective is to determine whether parental touch reduces noxious-evoked brain activity following a heel lance. In addition, our secondary and exploratory objectives include investigating the effect of touch on behavioural and electrophysiological measures evoked by a heel lance. Neonates will be randomised to receive parental touch either prior to or post a clinically required heel lance. We will also investigate how parental touch impacts post-procedural clinical stability and explore whether this intervention affects parental anxiety. Neonates will be recruited during a 9-month period. Participants will be studied on a single test occasion while they are in hospital, when they require a clinical heel lance. No extra blood tests or noxious procedures will be performed for the purpose of the study. Participants will be included in the study for approximately an hour period. This will be approximately 30 min before and after the time when the heel lance is performed. Individual babies will only be included in the trial once. If a neonate requires additional heel lances to acquire sufficient blood for clinical assessment at the time of the test occasion, we will also record the responses to this.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant Development, Pain, Procedural, Parents
Keywords
Parental touch, Brain activity, Stroking, Anxiety, Clinical pain score, Heart rate, Respiratory rate

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
112 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Parental touch (pre-procedural)
Arm Type
Experimental
Arm Description
Parents will stroke their baby on the posterior lower limb of the leg where the heel lance will be administered, at a speed of 3cm/s for 10 seconds using the whole hand and in one direction down the limb towards the foot. This will happen just before the control procedure and clinical heel lance.
Arm Title
Parental touch (post-procedural)
Arm Type
Placebo Comparator
Arm Description
Parents will stroke their baby on the posterior lower limb of the leg where the heel lance was administered, at a speed of 3cm/s for 10 seconds using the whole hand and in one direction down the limb towards the foot. This will happen just after the control procedure and clinical heel lance.
Intervention Type
Behavioral
Intervention Name(s)
Parental touch
Intervention Description
Parental touch in the form of stroking at 3cm/s for 10 seconds on the posterior lower limb where the heel lance will be/has been administered
Primary Outcome Measure Information:
Title
Magnitude of noxious-evoked brain activity
Description
An electroencephalography (EEG) template based on the Principal Component that reflects the noxious-evoked brain activity in neonates has been defined and validated in independent data sets (Hartley 2017). This template will be projected onto the EEG data recorded in the 1000ms period following each heel lance and heel lance control stimulus and the relative weight of the component calculated for each neonate. A greater weight indicates a stronger noxious-evoked response.
Time Frame
Immediately after heel lance (within 1000ms)
Secondary Outcome Measure Information:
Title
Premature Infant Pain Profile - Revised score (PIPP-R score)
Description
PIPP-R is a composite measure encompassing behavioural, physiological and contextual indicators involved in the pain response. These include gestational age, behavioural state, heart rate, oxygen saturation, and duration of brow bulge, eye squeeze, and nasolabial furrow. Each indicator in the PIPP-R is rated on a 4-point scale (0, 1, 2, and 3); these are summed together to produce a maximum possible score of 21, and minimum possible score of 0. In the revised PIPP-R, the scores for the contextual indicators (gestational age and behavioural state) are only included if a non-zero score is recorded for either the physiological or behavioural variables (Stevens et al., 2014). A higher score suggests a greater pain response.
Time Frame
During the 30s period after the heel lance
Title
Percentage of neonates who develop tachycardia
Description
Percentage of neonates who develop post-procedural tachycardia (in the 30 seconds post-heel lance). Tachycardia will be defined as a heart rate >160 beats per minute as per Advanced Paediatric Life Support guidelines, reflecting heart rate values >90th centile for newborns in the first week of life (Fleming et al., 2011; Schwartz et al., 2002).
Time Frame
During the 30s period after the heel lance
Title
Parental anxiety
Description
Anxiety score from the 20-point Stait Trait Anxiety Inventory (STAI), the gold standard for state anxiety. It is well validated and publicly available. The STAI has a trait (STAI-T) and a state version (STAI-S). The STAI-T scale consists of 20 statements that ask people to describe how they generally feel. The STAI-S scale also consists of 20 statements, but the instructions require subjects to indicate how they feel at a particular moment in time. The STAI-S scale can be used to determine the actual levels of anxiety intensity induced by stressful procedures. Each question is rated on a 4-point scale (not at all, somewhat, moderately so, very much so). The range of possible scores for form Y of the STAI varies from a minimum score of 20 to a maximum score of 80 on both the STAI-T and STAI-S subscales. STAI scores are commonly classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).
Time Frame
At the end of the test occasion, within 30 minutes of the heel lance
Other Pre-specified Outcome Measures:
Title
Exploratory outcome: changes in brain activity during parental touch intervention
Description
Changes in brain activity recorded using EEG, which are elicited during the parental touch intervention. This is an exploratory outcome, therefore data will be investigated with a pragmatic approach.
Time Frame
During parental touch intervention
Title
Exploratory outcome: time taken for heart rate to return to baseline post-heel lance
Description
Impact of parental touch prior to the clinical procedure on reducing the duration of time for heart rate to return to baseline after a clinically-essential heel lance, compared with post-procedural touch.
Time Frame
30 min time period after the clinical heel lance
Title
Exploratory outcome: post-procedural variability in respiratory rate, incidence of apnoea, and change in respiratory stability
Description
Changes in respiratory rate and respiratory stability recorded using electrocardiogram (ECG). The data will also identify incidence of apnoea; an episode of apnoea will be defined as the cessation in breathing for at least 20s. This is an exploratory outcome, therefore data will be investigated with a pragmatic approach. Variability in respiratory rate, incidence of apnoea and change in respiratory stability are considered as one exploratory outcome as they are recorded using the same measurement techniques and interrelated.
Time Frame
30 min time period after the clinical heel lance
Title
Exploratory outcome: parental views
Description
Scores for each emotion, experienced by the parent during the heel lance, using a 4-point distress score (worried/upset/anxious/sad), and responses to a questionnaire about participating in this study and general infant research.
Time Frame
At the end of the test occasion, within 30 minutes of the heel lance

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Days
Maximum Age & Unit of Time
7 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Participants born at the John Radcliffe Hospital, Oxford or the Royal Devon and Exeter Hospital, Devon Neonates born at or after 35+0 weeks gestation Neonates with a postnatal age of 7 days or less Neonates who clinically require a heel lance Neonates for whom parents/guardians have given written informed consent for inclusion in the trial Exclusion Criteria: Intraventricular haemorrhage (IVH) > grade II Received any analgesics or sedatives in the last 24 hours Congenital malformation or genetic condition known to affect neurological development Born to mothers who have a history of substance abuse.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eleri Adams
Organizational Affiliation
Oxford University Hospitals NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ravi Poorun
Organizational Affiliation
Royal Devon University Healthcare NHS Foundation Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oxford University Hospitals NHS Foundation Trust
City
Oxford
ZIP/Postal Code
OX3 9DU
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The data that support the findings of this study are available from the PI (rebeccah.slater@paediatrics.ox.ac.uk) listed on clinicaltrials.gov. The Study Protocol, Informed Consent Form and Statistical Analysis Plan will be available to download as a supplement to the final publication of the results.
IPD Sharing Time Frame
Available after the publication of final results.
IPD Sharing Access Criteria
PI will have discretion to share data with potential collaborators.
Citations:
PubMed Identifier
36250332
Citation
Cobo MM, Moultrie F, Hauck AGV, Crankshaw D, Monk V, Hartley C, Evans Fry R, Robinson S, van der Vaart M, Baxter L, Adams E, Poorun R, Bhatt A, Slater R. Multicentre, randomised controlled trial to investigate the effects of parental touch on relieving acute procedural pain in neonates (Petal). BMJ Open. 2022 Jul 19;12(7):e061841. doi: 10.1136/bmjopen-2022-061841.
Results Reference
derived

Learn more about this trial

Parental Touch Trial (Petal)

We'll reach out to this number within 24 hrs